{"nctId":"NCT01844115","briefTitle":"Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder","startDateStruct":{"date":"2013-04-30","type":"ACTUAL"},"conditions":["Generalized Anxiety Disorder"],"count":415,"armGroups":[{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"Vilazodone","type":"EXPERIMENTAL","interventionNames":["Drug: Vilazodone"]}],"interventions":[{"name":"Placebo","otherNames":["Matching 10 mg and 20 mg placebo tablets, once-daily oral administration."]},{"name":"Vilazodone","otherNames":["Vilazodone, 20 mg once per day, oral administration, once daily or Vilazodone, 40 mg once daily, oral administration, once daily"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female outpatient, 18-70 years of age\n* Currently meet the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria for Generalized Anxiety Disorder\n* Minimum score of 20 on Hamilton Rating Scale for Anxiety\n\nExclusion Criteria:\n\n* Women who are pregnant or who will be breastfeeding during the study\n* Patients with a history of:\n\n  1. Any manic or hypomanic or mixed episode, including bipolar disorder and substance-induced manic, hypomanic or mixed episode\n  2. Any depressive episode with psychotic or catatonic features\n  3. Panic disorder with or without agoraphobia","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in the Hamilton Rating Scale for Anxiety (HAM-A) Total Score","description":"The Hamilton Anxiety Rating Scale (HAM-A) is a clinician-administered scale which consists of 14 items, each rated on a five point scale ranging from 0 (not present) to 4 (very severe). The highest possible score is 56, which represents the most severe form of anxiety; the lowest possible score is 0, which represents an absence of anxiety.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14.7","spread":"7.41"},{"groupId":"OG001","value":"11.3","spread":"6.99"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in the Sheehan Disability Scale (SDS) Total Score","description":"The Sheehan Disability Scale (SDS) is a 3-item clinician-rated questionnaire used to evaluate impairments in the domains of work, social life/leisure, and family life/home responsibility. All items are rated on an 11-point continuum (0 = no impairment to 10 = most severe) with the total SDS score ranging from 0 (no impairment) to 30 (most severe).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.2","spread":"6.96"},{"groupId":"OG001","value":"7.4","spread":"6.96"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":202},"commonTop":["Nausea","Diarrhoea","Headache","Dizziness","Dry mouth"]}}}